Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-11-26 Purchase |
2024-11-27 5:09 pm |
Pyxis Oncology Inc. | PYXS | Connealy Pamela Ann CFO & COO |
88,850 | $1.9625 | $174,364 | 1,199,143 (Indirect) |
View |
| 2023-09-28 Purchase |
2023-09-28 4:32 pm |
Pyxis Oncology Inc. | PYXS | Connealy Pamela Ann CFO and COO |
8,000 | $1.87 | $14,960 | 818,532 (Direct) |
View |
| 2023-09-27 Purchase |
2023-09-27 6:36 pm |
Pyxis Oncology Inc. | PYXS | Connealy Pamela Ann CFO and COO |
6,426 | $1.8468 | $11,868 | 810,532 (Direct) |
View |
| 2023-09-25 Purchase |
2023-09-25 5:04 pm |
Pyxis Oncology Inc. | PYXS | Connealy Pamela Ann CFO and COO |
12,000 | $1.6703 | $20,044 | 804,106 (Direct) |
View |
| 2023-09-22 Purchase |
2023-09-22 7:34 pm |
Pyxis Oncology Inc. | PYXS | Connealy Pamela Ann CFO and COO |
5,000 | $1.739 | $8,695 | 792,106 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-31 Option Award |
2025-04-02 08:56 am |
N/A 2035-03-31 |
Pyxis Oncology Inc. | PYXS | Connealy Pamela Ann CFO & COO |
414,163 | $0.98 | 414,163 (Direct) |
View |
| 2024-12-23 Option Award |
2024-12-23 4:30 pm |
N/A 2034-12-23 |
Pyxis Oncology Inc. | PYXS | Connealy Pamela Ann CFO & COO |
310,000 | $0 | 310,000 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-21 5:57 pm |
2025-06-20 2034-06-20 |
Orchestra BioMed Holdings Inc. | OBIO | Connealy Pamela Ann Director |
22,444 | $0 | 38,357 (Direct) |
View |
| 2024-03-26 Option Award |
2024-03-28 4:33 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Connealy Pamela Ann CFO & COO |
328,710 | $0 | 1,110,293 (Direct) |
View |
| 2023-11-29 Tax Withholding |
2023-11-30 4:15 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Connealy Pamela Ann CFO and COO |
36,949 | $1.4 | 781,583 (Direct) |
View |
| 2023-09-07 Option Award |
2023-09-08 5:02 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Connealy Pamela Ann CFO and COO |
187,793 | $0 | 782,106 (Direct) |
View |
| 2023-07-20 Option Award |
2023-07-24 5:11 pm |
2024-07-20 2033-07-20 |
Orchestra BioMed Holdings Inc. | OBIO | Connealy Pamela Ann Director |
29,167 | $0 | 33,413 (Direct) |
View |
| 2023-01-26 Option Award(A) |
2023-05-19 5:45 pm |
N/A 2032-08-17 |
Orchestra BioMed Holdings Inc. | OBIO | Connealy Pamela Ann Director |
23,250 | $0 | 23,250 (Direct) |
View |
| 2023-04-12 Exercise |
2023-05-05 8:18 pm |
N/A N/A |
Orchestra BioMed Holdings Inc. | OBIO | Yanchik Connealy Pamela Director |
758 | $0 | 5,004 (Direct) |
View |
| 2023-01-26 Option Award(A) |
2023-05-05 8:11 pm |
N/A N/A |
Orchestra BioMed Holdings Inc. | OBIO | Yanchik Connealy Pamela Director |
1,516 | $0 | 1,516 (Direct) |
View |
| 2023-03-24 Option Award |
2023-03-28 4:47 pm |
N/A 2031-07-30 |
Pyxis Oncology Inc. | PYXS | Yanchik Connealy Pamela CFO and COO |
542,372 | $0 | 926,882 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 9:34 pm |
N/A 2030-06-29 |
Orchestra BioMed Holdings Inc. | OBIO | Yanchik Connealy Pamela Director |
45,338 | $0 | 45,338 (Direct) |
View |
Ownership |
2023-01-30 9:19 pm |
N/A 2028-01-26 |
Orchestra BioMed Holdings Inc. | OBIO | Yanchik Connealy Pamela Director |
0 | $0 | 15,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-03 7:37 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Yanchik Connealy Pamela Chief Financial Officer |
43,493 | $0 | 384,510 (Direct) |
View |
| 2022-04-14 Option Award |
2022-04-15 8:00 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Yanchik Connealy Pamela Chief Financial Officer |
93,493 | $0 | 341,017 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 4:15 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Yanchik Connealy Pamela Chief Financial Officer |
247,524 | $0 | 247,524 (Direct) |
View |
| 2021-12-06 Option Award |
2021-12-07 3:36 pm |
N/A 2031-12-06 |
Pyxis Oncology Inc. | PYXS | Yanchik Connealy Pamela Chief Financial Officer |
52,944 | $0 | 52,944 (Direct) |
View |
Ownership |
2021-10-07 9:07 pm |
N/A 2031-07-30 |
Pyxis Oncology Inc. | PYXS | Yanchik Connealy Pamela Chief Financial Officer |
0 | $0 | 332,569 (Direct) |
View |
| 2021-03-19 Option Award |
2021-03-23 08:45 am |
N/A 2031-03-19 |
Immunovant Inc. | IMVT | Yanchik Connealy Pamela Chief Financial Officer |
208,200 | $0 | 208,200 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-18 08:31 am |
N/A 2030-05-14 |
Immunovant Inc. | IMVT | Yanchik Connealy Pamela Chief Financial Officer |
180,500 | $0 | 180,500 (Direct) |
View |